Abstract presenter at PCRS Conference

Conference 2024 Abstracts

💡 The latest in respiratory research and best practice / service development to inspire your work.

Listed below are all the accepted abstracts from the PCRS Respiratory Conference 2024.

73 results

Severe Asthma Care Reimagined: Bridging Gaps for Equitable Access from Primary to Specialist Care (ID 556)

Howell A, McGuigan H, Chadwick A

University of Oxford

A toolkit to support asthma diagnosis in children and young people (ID 557)

Hamilton J, Marsh V, Cummings L.

Black Country Integrated Care Board

Excellence in Asthma for children and young people: a quality improvement project (QIP) in primary care (ID 558)

Cummings L, Hamilton J, Marsh V, Saiyed, S, Tipping L.

Black Country Integrated Care Board

Service evaluation of an integrated respiratory service in identifying and supporting patients with severe asthma on biologics (ID 560)

Gupta A, Evans R, Lowrey G, Chang W, Aldridge R, Subramanian D

Respiratory department, Royal Derby Hospital, Derby, UK

Evaluation of a psychology mindfulness and compassion focused group programme for patients with a range of respiratory conditions (ID 565)

Ryder M, Graham L, Packer K, El Hakim R

Homerton Healthcare

Reducing Short Acting Beta-2 agonist (SABA) inhaler overuse in Asthma using a population health management (PHM) approach and digital intelligence (ID 572)

Merson S, Chaloner J, McConnell WD, Watson J

Dorset ICS

Addressing cardiopulmonary risk in COPD patients across North Belfast GP Federation ​(NBF) (ID 575)

Corry M, Haughey C, Burns MT,

North Belfast GP Federation

Mid and South Essex Long COVID Service: Service transformation through innovation, co-production and continuous evolution (ID 578)

Barlow R, Cox K, McGough-Heath C, Lambert A, Branson R, Hancock P.

Provide Community Interest Company

An Innovative use of data to improve the care of COPD patients in Midlothian Community Respiratory Team (ID 583)

Yerramasu C, Farquhar J, DuBou N, Johnston E, Curl M.

Nhs Lothian

Tackling inappropriate OCS usage in severe asthma (ID 585)

Malik NM, Fardon T, Faruqi S, Heaney LG, Hickman K, Whittamore A

GSK, London, UK

Implementing Maintenance and Reliever Therapy for adults with asthma aged 17 years and older in a primary care surgery over a 12-month period: Effects on inhaled corticosteroid prescribing, short-acting β2-agonist reliance and severe exacerbations. (ID 497)

Parsons S, Trudgill J

Kennedy Way Surgery

Expediting specialist review of patients with uncontrolled asthma in primary care via virtual multidisciplinary meeting and digital patient identification tool (ID 511)

Gautam K, Mohamed R, Shah M, Logan R, Wong EHC

Imperial College Healthcare NHS Trust, North Southall PCN, Imperial College Health Partners

Risk factors for asthma death and life-threatening attacks in children – a systematic review (ID 517)

Gawlik-Lipinski A, Nalir Hassen S, Ramphul M, Quint JK, Gillies C, Lo DKH

University of Leicester

Public Health Impact Assessment of RSVPreF3 OA Adjuvanted Vaccine on Respiratory Syncytial Virus in Selected European Countries (ID 525)

Zarkadoulas E, Kostakis A, Uhl G, Selke B, Dich NV, Garcia A, Vallejo-Aparicio LA, Riaz S, Jakola J, Akratos A, Lucey D, O'Kane J, Berghuis S, Jongeneel G, Gjonnes L, Boge G, Bota P, Mardberg K, Danielsson L, Marijam A

GSK

Integrating Primary and Secondary Care for Breathlessness: Development of a Holistic Multidisciplinary Team – A Pilot Project (ID 527)

Cole A, Bhabra M, Macnair A, Hughes J

South Tyneside and Sunderland Foundation Trust

RESPiRe (Respiratory Education, Self-Management and Pulmonary rehabilitation), Evaluating the Impact of Group Education for COPD Management. (ID 528)

Mansoor M (GP Respiratory Clinical lead), Horsley R (GP Research Lead), Hinson G (Social prescribing lead), Humphries M (Pulmonary rehabilitation lead), Lonsdale J(Healthy Lifestyles Development Officer), Crocker H(Evaluation Researcher), McBain H(Evaluation Lead), Jorgensen M(Programme Manager)

The Ridings Medical Group, East Riding of Yorkshire

Evaluation of A New On-the-Go Spacer for Delivery of A MART Metered Dose Inhaler Therapy (ID 529)

M. Nagel, J. Suggett, L. Clutterbuck

Trudell Medical International

Severe asthma biologics use in England: a need to increase use and reduce inequity (ID 535)

Rupani H, Subramanian D, Walker S, Bostock B

University Hospital Southampton NHS Foundation Trust

Effectiveness and acceptability of asynchronous digital health in asthma care: a mixed-methods systematic review (ID 548)

Uzzaman N, Hammersley V, McClatchey K, Sheringham J, Singh D, Habib GMM, Pinnock H

The University of Edinburgh

Lived experiences from asthma exacerbation recovery: new thoughts. (LEARNT) (ID 554)

Naccarato E, Akter N, Sahar T, Pal A, Musaliar N, Hodgson M, Smith D, Hodgson D, Pradhan A

Respiratory Department Kingsmill Hospital - Sherwood Forest Hospitals

Service development and evaluation of a pharmacist-led Respiratory Diagnostic Hub in a PCN (ID 574)

Long P, Al Khalil Y, Chen YCS, May L

Chiswick PCN

Proactive identification of Uncontrolled Severe Asthma Patients within Humber and North Yorkshire ICS to Address Inequalities in access to Asthma Biologics: The Pro-HNY-Bio Project (ID 581)

Riches C, Cummings H, Faruqi S, Crick J, Smith H, Crooks MG

Hull University Teaching Hospitals NHS Trust

Severe asthma patient identification, review, and referral; a Joint Working project between Hull University Teaching Hospitals NHS Trust and GlaxoSmithKline UK Ltd (GSK) in Humber and North Yorkshire Integrated Care System (ICS), the UNITE Service (ID 582)

Faruqi S, Ruddy T, Barry G, Cummings H, Crooks MG

Hull University Teaching Hospitals NHS Trust

The conference has been instigated and organised by PCRS. We are grateful to sponsors and exhibitors who have contributed funding towards this event in return for exhibition space. Neither sponsors or exhibitors have had any input into the agenda or the selection of speakers with the exception of any sponsored satellite symposia which are clearly indicated. View the full list of sponsors.

Thank you to this year's conference sponsors

AstraZeneca (UK) Limited
Boehringer Ingelheim Ltd
Chiesi Ltd
GSK
Sponsors have had no input into the agenda of the conference, with the exception of the satellite symposium sessions, for which the sponsoring companies are fully responsible.
A full list of conference exhibitors can be found at www.pcrs-uk.org/conference-exhibitors